J.A. Carrión

5.2k total citations
85 papers, 2.0k citations indexed

About

J.A. Carrión is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, J.A. Carrión has authored 85 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Hepatology, 65 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in J.A. Carrión's work include Liver Disease Diagnosis and Treatment (61 papers), Hepatitis C virus research (54 papers) and Liver Disease and Transplantation (32 papers). J.A. Carrión is often cited by papers focused on Liver Disease Diagnosis and Treatment (61 papers), Hepatitis C virus research (54 papers) and Liver Disease and Transplantation (32 papers). J.A. Carrión collaborates with scholars based in Spain, United States and Italy. J.A. Carrión's co-authors include Xavier Forns, Miquel Navasa, Miquel Bruguera, Gonzalo Crespo, Rosa Gilabert, Juan Carlos García‐Pagán, Jaime Bosch, Jaume Bosch, Montserrat Garcı́a-Retortillo and Rosa Miquel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

J.A. Carrión

83 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.A. Carrión Spain 22 1.7k 1.7k 277 121 62 85 2.0k
Gonzalo Crespo Spain 22 1.6k 1.0× 1.7k 1.0× 465 1.7× 205 1.7× 54 0.9× 90 2.3k
Pier Luigi Calvo Italy 19 892 0.5× 790 0.5× 243 0.9× 79 0.7× 116 1.9× 72 1.3k
Fulvio Mozzi Italy 17 964 0.6× 1.4k 0.8× 159 0.6× 112 0.9× 85 1.4× 26 1.7k
Renata de Mello Perez Brazil 18 857 0.5× 865 0.5× 131 0.5× 70 0.6× 35 0.6× 93 1.1k
Jorge Rakela United States 20 1.1k 0.7× 964 0.6× 305 1.1× 70 0.6× 48 0.8× 28 1.3k
Ziv Ben Ari Israel 16 893 0.5× 806 0.5× 201 0.7× 245 2.0× 57 0.9× 38 1.3k
Karl Barange France 18 1.4k 0.8× 1.2k 0.7× 487 1.8× 173 1.4× 79 1.3× 61 1.8k
Rami Moucari France 26 2.6k 1.5× 2.5k 1.5× 234 0.8× 184 1.5× 128 2.1× 49 2.9k
Leonardo de Lucca Schiavon Brazil 19 753 0.4× 825 0.5× 175 0.6× 63 0.5× 63 1.0× 99 1.2k
Yılmaz Çakaloğlu Türkiye 26 3.4k 2.0× 3.4k 2.0× 210 0.8× 260 2.1× 56 0.9× 83 3.8k

Countries citing papers authored by J.A. Carrión

Since Specialization
Citations

This map shows the geographic impact of J.A. Carrión's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Carrión with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Carrión more than expected).

Fields of papers citing papers by J.A. Carrión

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Carrión. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Carrión. The network helps show where J.A. Carrión may publish in the future.

Co-authorship network of co-authors of J.A. Carrión

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Carrión. A scholar is included among the top collaborators of J.A. Carrión based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Carrión. J.A. Carrión is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Seng Gee, Marc Bourlière, Nathalie Ganne‐Carrié, et al.. (2025). HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER). Gut. gutjnl–2025. 1 indexed citations
2.
Bertot, Luis Calzadilla, Anna Sòria, Isabel Badell, et al.. (2025). Predicting Hepatic Decompensation in Patients With Metabolic Dysfunction Associated Steatotic Liver Disease‐Related Cirrhosis: The ABID‐LSM Model. Alimentary Pharmacology & Therapeutics. 62(5). 526–535.
3.
León, Francisco, et al.. (2025). Clinical Ascites and Emergency Procedure as Determinants of Surgical Risk in Patients with Advanced Chronic Liver Disease. Journal of Clinical Medicine. 14(4). 1077–1077. 1 indexed citations
4.
Olivas, Pol, Luís Téllez, J.A. Carrión, et al.. (2024). Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradient. JHEP Reports. 6(10). 101170–101170. 2 indexed citations
5.
Carrión, J.A., et al.. (2023). Past, present, and future of long-term treatment for hepatitis B virus. World Journal of Gastroenterology. 29(25). 3964–3983. 12 indexed citations
6.
García‐Cehic, Damir, Ariadna Rando‐Segura, Francisco Rodríguez‐Frias, et al.. (2021). Resistance‐associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure. Journal of Viral Hepatitis. 28(9). 1319–1324. 6 indexed citations
7.
Rodríguez‐Tajes, Sergio, Ángela Domı́nguez, J.A. Carrión, et al.. (2020). Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals. Journal of Gastroenterology and Hepatology. 35(9). 1570–1578. 29 indexed citations
8.
Garcı́a-Retortillo, Montserrat, Marc Puigvehí, Núria Cañete, et al.. (2020). Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients. World Journal of Hepatology. 12(11). 1076–1088. 12 indexed citations
9.
Cacoub, P., Peter Buggisch, J.A. Carrión, et al.. (2018). Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe. Journal of Viral Hepatitis. 25(7). 811–817. 22 indexed citations
10.
Puigvehí, Marc, S. Coll, Montserrat Garcı́a-Retortillo, et al.. (2016). Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years. PLoS ONE. 11(12). e0164883–e0164883. 11 indexed citations
11.
Garcı́a-Retortillo, Montserrat, Núria Cañete, S. Coll, et al.. (2014). Drug–drug interactions of telaprevir and boceprevir in HCV ‐monoinfected and HIV / HCV ‐coinfected patients can modify the adherence. Liver International. 35(5). 1557–1565. 5 indexed citations
12.
Londoño, María‐Carlota, Christie Perelló, Joaquín Cabezas, et al.. (2014). The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis. Journal of Hepatology. 62(2). 311–316. 10 indexed citations
13.
Carrión, J.A.. (2012). Evaluación de la fibrosis asociada a la enfermedad hepática. Gastroenterología y Hepatología. 35. 38–45. 3 indexed citations
14.
Coto‐Llerena, Mairene, Sofía Pérez‐del‐Pulgar, Gonzalo Crespo, et al.. (2011). Donor and Recipient IL28B Polymorphisms in HCV-Infected Patients Undergoing Antiviral Therapy before and after Liver Transplantation. American Journal of Transplantation. 11(5). 1051–1057. 63 indexed citations
15.
Carrión, J.A., Miquel Navasa, & Xavier Forns. (2010). Retransplantation in patients with hepatitis C recurrence after liver transplantation. Journal of Hepatology. 53(5). 962–970. 53 indexed citations
16.
Carrión, J.A., Ferràn Torres, Gonzalo Crespo, et al.. (2009). Liver Stiffness Identifies Two Different Patterns of Fibrosis Progression in Patients With Hepatitis C Virus Recurrence After Liver Transplantation. Hepatology. 51(1). 23–34. 97 indexed citations
17.
Massaguer, Anna, Santseharay Ramírez, J.A. Carrión, et al.. (2007). Evolution of the NS3 and NS5B Regions of the Hepatitis C Virus During Disease Recurrence After Liver Transplantation. American Journal of Transplantation. 7(9). 2172–2179. 7 indexed citations
18.
Feliu, Anna, J.A. Carrión, Anna Massaguer, et al.. (2006). Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection. Journal of Viral Hepatitis. 13(8). 544–551. 8 indexed citations
19.
Carrión, J.A., Miquel Navasa, Jaume Bosch, et al.. (2006). Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transplantation. 12(12). 1791–1798. 322 indexed citations
20.
Piñol, Virgı́nia, M Pagès, Antoni Castells, et al.. (2004). Utilidad de la colonografía por tomografía computarizada en la detección de pólipos colorrectales. Medicina Clínica. 123(2). 41–44. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gonzalo Crespo Breakdown of academic impact, for papers by Pier Luigi Calvo Breakdown of academic impact, for papers by Fulvio Mozzi Breakdown of academic impact, for papers by Renata de Mello Perez Breakdown of academic impact, for papers by Jorge Rakela Breakdown of academic impact, for papers by Ziv Ben Ari Breakdown of academic impact, for papers by Karl Barange Breakdown of academic impact, for papers by Rami Moucari Breakdown of academic impact, for papers by Leonardo de Lucca Schiavon Breakdown of academic impact, for papers by Yılmaz Çakaloğlu
Rankless by CCL
2026